Tarchomin Pharmaceutical Works "Polfa" S.A.
Budget
€10 — €0
EP Access
0
accredited persons
Staff
4
0.4 FTE
EU Grants
None
Mission & Goals
Polish generic pharmaceutical company, producer of APIs and FDFs critical for European and international markets. Company with 200 years of history in pharma business. The only polish penicillin's manufacturer, a strong player in antibiotics market, producer of human insulin, highly experienced in sterile production. We heavily invest in new state of the art production facility dedicated to hilgly potent drugs.
EU Legislative Interests
EMA/528805/2023 Union list of critical medicines - version 1 Vulnerabilities in critical medicines supply chains CMA
Communication Activities
https://www.ema.europa.eu/en/news/first-version-union-list-critical-medicines-agreed-help-avoid-potential-shortages-eu https://health.ec.europa.eu/health-emergency-preparedness-and-response-hera_en https://health.ec.europa.eu/health-emergency-preparedness-and-response-hera/overview/critical-medicines-alliance_en https://www.edqm.eu/en/groups-of-experts-and-working-parties
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
EDQM
Organisation Members
Rafał Łunio - Expert in EDQM Working Group Monika Janicka - Expert in EDQM Working Group
Commissioner Meetings
No recorded meetings with EU commissioners.